ShakB(N+16) increases, and ShakB(N) decreases, NB coupling. by Sami H. Jezzini (650703)

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Decreased expression of MHCII in antigen presenting cells from the lungs of IL-19-/- mice. by Carol Hoffman (196241)

Absence of PICALM results in a decreased rate of internalization and increased cell surface expression of TfR in MEFs. by Paula B. Scotland (138601)

Ovariectomy decreases CA1 apical dendrite spine density in female apoE3 TR mice. by Rebecca C. Klein (551567)

<i>Gnas</i> deletion in hypothalamic <i>Opn5</i> neurons. by Kevin D. Gaitonde (15411707)

Subjects:

CB₁R activity increases while DOR activity decreases in cortex of lesioned animals. by Ittai Bushlin (191060)

High glucose induced intracellular accumulation of methylglyoxal, which in turn led to decreased levels of HIF-1α. by Carla Figueira Bento (359400)

Rosuvastatin treatment decreases the levels of OVA-IgE and angiogenesis-related cytokines in the serum. by Lei Zhang (38117)

GBE did not modify cell morphology but decreased reactive oxygen species (ROS) levels. by Virginie Rhein (243241)

“…<b>D</b>) ROS levels (DHR fluorescence units/1×10⁵ cells normalized to the respective untreated control and APP cells = 100%) were significantly decreased after treatment with GBE (100 µg/ml; 24 h). …”

Decreased desaturation of fatty acids in WAT, plasma and liver from HSL null mice. by Céline Fernandez (88202)

UNC-62 RNAi decreases expression of collagen genes and increases expression of intestinal genes. by Eric L. Van Nostrand (30730)

“…The histogram indicates the distribution of genes by average fold-change upon <i>unc-62</i> RNAi. For 1699 genes with intestine-enriched expression <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003325#pgen.1003325-McGhee1" target="_blank">[23]</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003325#pgen.1003325-Pauli1" target="_blank">[33]</a>, <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003325#pgen.1003325-Spencer1" target="_blank">[34]</a> as well as the subset of 291 genes that also decrease expression with age <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003325#pgen.1003325-Budovskaya1" target="_blank">[10]</a>, we determined the average mean-centered fold-change from triplicate RNA-seq experiments of <i>unc-62</i> RNAi as compared to controls. …”

Mutation of the genes encoding the SpuDEFGH transporter decreased the expression of T3SS genes. by Lian Zhou (272766)

Decreased TRAF6 levels are sufficient to impair host control of influenza virus replication. by Carrie M. Rosenberger (42649)

SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice. by Jun Yu (5904)

“…Right panel shows the quantification of percentage of suvivin positive staining in total vessel area. Values are mean ± SEM; n = 5. * P<0.05, ** P<0.001 with one way ANOVA with Bonferroni posttest.…”

DataSheet_1_Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.xlsx by Murielle Golomingi (13239774)

Fluoxetine decreases the levels of abundant neuropeptides (NPY and CART) in hypothalamic differentiated neuroprogenitor cells. by Lígia Sousa-Ferreira (221509)

“…<p>Fluoxetine decreases the mRNA levels of neuropeptides that are abundant in differentiated hypothalamic neuroprogenitor cultures NPY (<b>A</b>) and CART (<b>D</b>), but has no effect in the mRNA of AgRP (<b>B</b>) and POMC (<b>C</b>). …”

LPC 18:1 lowers NO bioavailability and decreases eNOS dimer in EA.hy926 endothelial cells. by Andrijana Kozina (665147)

Prolonged exposure to oxidized LDL particles decreases Cx36 levels in β-cells. by Jacques-Antoine Haefliger (134116)

Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging. by Fan Ding (302565)

“…This rise sustained across 6, 9 and 12 months of age and then decreased significantly at 15 months of age. D. In nonTg hippocampus, there was a trend towards increased expression of GLUT1_{45 Kda} from 3 to 12 months of age. …”